PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930135
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930135
The global bioinformatics services market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 22.03 billion by 2034, registering a robust CAGR of 13.83% during the forecast period. North America dominated the market with a share of 45.87% in 2025, supported by strong research infrastructure, large-scale genomic initiatives, and the presence of major service providers.
Bioinformatics is an interdisciplinary field integrating computer science, biostatistics, and life sciences to analyze and interpret vast volumes of biological data. Bioinformatics services play a crucial role in genomic and proteomic biomarker discovery, drug development, disease diagnosis, and personalized medicine. The expanding application of these services across healthcare, agriculture, forensic science, veterinary science, and biotechnology is accelerating global market penetration.
Market Drivers
One of the primary growth drivers is the rising adoption of cloud-based bioinformatics solutions, which reduce operational costs and improve accessibility to large clinical datasets. Governments and healthcare organizations are increasingly focusing on implementing these solutions to accelerate research workflows and meet the growing demand for personalized medicine.
The increasing outsourcing of bioinformatics services by pharmaceutical and biotechnology companies to analyze clinical trial and drug discovery data has further boosted market growth. Rapid innovation in genomics, proteomics, and biopharmaceutical research is driving demand for advanced data interpretation services.
During the COVID-19 pandemic, the bioinformatics services market experienced positive growth due to the urgent need to analyze viral genomic data. Increased investments by governments and industry players to support vaccine and therapeutic development significantly contributed to revenue growth during this period.
Market Trends
A key trend shaping the market is the growing application of bioinformatics in personalized medicine and vaccine development. Advanced sequencing technologies and analytical tools enable precise diagnosis, targeted therapies, and improved treatment outcomes with reduced side effects.
Bioinformatics is increasingly used in gene sequencing diagnostics, disease risk prediction, drug discovery, and personalized vaccination strategies. The integration of artificial intelligence and machine learning into genomic data analysis is further enhancing research efficiency while reducing time and cost associated with clinical studies.
Restraining Factors
Despite strong growth prospects, the market faces challenges related to data management, standardization, and ethical concerns. Managing diverse and complex biological datasets requires skilled professionals, which are in limited supply in emerging regions.
Ethical and legal issues related to genomic data storage, sharing, and privacy remain unresolved in many countries. Additionally, the lack of standardized guidelines for handling large-scale biological datasets and the need for continuous upgrades in sequencing and data storage infrastructure may restrict market growth to some extent.
By Service Type:
The sequencing segment dominated the market with a share of 37.72% in 2026, driven by the widespread adoption of next-generation sequencing technologies and declining sequencing costs. Data analysis and drug discovery services also held substantial market shares due to their critical role in genomics and pharmaceutical research.
By Application:
The genomics segment accounted for 35.68% of the global market share in 2026, supported by increasing genomic research programs and government funding. Metabolomics and pharmacology also contributed significantly, while transcriptomics offers emerging growth opportunities.
By End User:
The pharmaceutical and biotechnology companies segment dominated with a 45.52% share in 2026, driven by extensive clinical research activities and the integration of bioinformatics to accelerate drug discovery. CROs and research institutes also held a significant share due to cost and time efficiency.
Competitive Landscape
Key players include Illumina, QIAGEN, Thermo Fisher Scientific, Eurofins Scientific, CD Genomics, and Excelra. These companies focus on strategic collaborations, acquisitions, and technological advancements to expand their service offerings and global presence.
Conclusion
The global bioinformatics services market is poised for significant growth from 2025 to 2034, driven by rising demand for genomic data analysis, personalized medicine, and drug discovery services. While challenges related to data management and ethical concerns persist, continuous technological advancements, strong government support, and expanding applications across healthcare and life sciences are expected to sustain market momentum. By 2034, the market is projected to reach USD 22.03 billion, reflecting the growing importance of bioinformatics services in modern biomedical research and healthcare innovation.
Segmentation By Service Type
By Application
By End User
By Region